Biovie Inc.
- Last sale
- Nov 6, 2026
- Market cap
- —
- no share count on file
- Filings
- 512
Q1 2016
—Q1 2027N/M FY26 yoy
Q1 2027N/M FY26 yoy
—
—
—Q1 2027N/M FY26 yoy
Q1 2027−48.8% FY26 yoy
Price
Nov 6, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-06-30 | $13,962,360 | reported | |
| FY 2025 | 2025-06-30 | $9,266,734 | reported | |
| FY 2024 | 2024-06-30 | $23,100,394 | reported | |
| FY 2023 | 2023-06-30 | $33,299,503 | reported | |
| FY 2022 | 2022-06-30 | $17,258,341 | reported | |
| FY 2021 | 2021-06-30 | $2,544,648 revised | reported | |
| FY 2020 | 2020-06-30 | $1,150,581 | reported | |
| FY 2018 | 2019-06-30 | $1,008,100 | reported | |
| FY 2017 | 2018-06-30 | $370,852 | reported | |
| FY 2016 | 2016-06-30 | $37,901 | reported | |
| FY 2015 | 2015-06-30 | $4,196 | reported |
Pharmaceutical preparations
Biovie Inc. is the 408th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
OTLCOncotelic Therapeutics, Inc.———$13.7MMTNBMatinas BioPharma Holdings, Inc.———$13.7MELABPMGC Holdings Inc.$590.1K—1,313.0%$13.4M
BIVIWBiovie Inc. (this company)———$12.7M
BOLTBolt Biotherapeutics, Inc.$7.7M0.1%433.7%$12.6MPPCBPropanc Biopharma, Inc.———$12.4MASBPAspire-Lakewood Holdings, Inc.$6.2K—394,725.1%$12.2MPTNPalatin Technologies Inc$13.2M—63.5%$12.2MONCOOnconetix, Inc.$815.4K67.7%1,721.0%$12.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR